Frontlight ResearchEarly access
Fabry disease trials in Taiwan
1 of 4 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking people4D-310 in Adults With Fabry Disease and Cardiac Involvement
- Where
- Taipei
- Age
- 18 years to 65 years
- People
- 18 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT05629559